SCREENING OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE USING NON-INVASIVE METHODS IN CLINICAL PRACTICE
DOI:
https://doi.org/10.24144/2077-6594.4.2019.193531Keywords:
NAFLD – Non-Alcoholic fatty liver disease, NASH – Non-alcoholic steatohepatitis, obesity, diabetes mellitus, transient elastography, ultrasonography, liver fibrosis indicesAbstract
The aim of study: to find out the incidence of non-alcoholic fatty liver disease in the internal outpatient clinic during 2017–2018 and compare the degree of liver damage found through transient elastography and fibrosis indices.
Materials and methods. A total of 742 new patients were examined in the outpatient clinic. In each new patient we performed blood sample examination and a USG examination. When an enlarged liver or fatty liver was detected, a transient elastography was done. We included 300 patients in our sample. Besides that we used selected liver fibrosis indices for detection of liver fibrosis and compared the results with fibroscan. We realized statistical analysis of results. The aim of the statistical analysis was to find out the mutual correlations of the monitored parameters, indices of liver damage and degree of liver damage (using fibroscan), the influence of the presence of diabetes mellitus on the degree of liver damage.
Results. The results of the multivariant analysis confirm the conclusions of the univariate analysis and can be summarized as follows: a) Independent predictors of liver damage are obesity, DM and patient’s age; b) Independent predictors of DM is obesity and age of patients (p = 0.001); c) Gender, as expected, does not appear to be a predictive factor.
Conclusions. The results of statistical analysis of liver fibrosis indices in a group of patients confirmed the validity of laboratory tests in assessing liver damage as well as their easy applicability for clinical practice. However, a comprehensive assessment of a patient using the fibrosis index, abdominal cavity ultrasound examination and transient elastography examination is ideal.
References
Belovičová M.: Non-Alcoholic fatty liver disease and its impact on public health. Krakow: Towarzystwo Slowakow w Polsce. 2019. 95 pp.
Bellentani S., Scaglioni F., Marino M., Bedogni G 2010: Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010; 28: 155161.
Castera, L. et al.: Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of Hepatology 2009; 50: 59-68.
Koller,T. NAFLD Summit 2018. Trends in hepatology 2018; 10(2): 4-7.
Belovičová, M.: Selected liver diseases. Textbook for medical students. 1. ed., Bardejov: SSPO, 2018, 111p.
Belovičová, M., Fedorková, I., Balážová, I.: Transient elastography – screening method for diagnosis of non-alcoholic fatty liver disease in obese patiens. Social Health Spectrum 1.02.2017.
Kruger, FC., Daniels, CR., Kidd, M., Swart, G., Brundyn, K., Rensburg, KV., Kotze, M.: APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S Afr Med J. 2011; 101: 477-80.
Castera, L., Yuen Chan, HL., Arrese, M. et al.: Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology 2015; 63: 237 – 264.
Koula, M., Hrúzová, M., Harmáček, D. et al.: Methods of non-invasive determination of liver fibrosis. Gastroent Hepatol 2016; 70(2): 118-124.
Angulo, P., Hui, JM., Marchesini, G. et al.: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2012; 45:846–54.
Belovičová, M., Mašterová, V.:Non-alcoholic fatty liver disease – severe comorbidity of diabetes. Forum Diab 2016; 5(1): 45-48.
Brúha, R., Dvořák, K., Petrtýl, J.: Liver disease in diabetics. Internal Medicine 2013; 59(7): 546-550.
Brúha, R.:Hepatic impairment screening in patients with type 2 diabetes mellitus Gastroent hepatol 2015; 69(4): 365-367.
Popovičová, M. – Kovácsová, B. 2016. Importance of fasting and postprandial glycemia in prevention of diabetic retinopathy. In Florence. Prague: Ambit Media, a. s., ISSN 1801-464X, 2016, vol. 7, no. 11., p. 18-22.
Barkasi, D. 2018. Diabetic in the process of education. In: DIAspectrum. ISSN: 1337-592X, 2018, vol. VII., No. 1/2018, p. 12–13.
Koller, T. Current trends in laboratory diagnosis of liver diseases at EASL 2019. Trends in hepatology 2019; 11(1): 6-7.
Zima, M. Non-alcoholic fatty liver disease. Viapract., 2008, 5 (4/5): 166-169.
